FOXD1 and lip and oral cavity carcinoma: It has been reported that FOXD1 is extensively detected in oral cancer tissues and associated with poor outcome in patients receiving irradiation since it may lessen anti-cancer radiotherapy effectiveness and immune surveillance [30].